WuXi AppTec Laboratory Testing Division Becomes DCAT Member

March 2, 2018 PAO-M03-18-NI-002

WuXi AppTec Laboratory Testing Division has joined DCAT.

WuXi AppTec Laboratory Testing Division has become a member of The Drug, Chemical & Associated Technologies Association (DCAT). DCAT is a non-for-profit, member-supported, global business development association for companies engaged in the business of pharmaceutical development and manufacturing.

WuXi Laboratory Testing Division will be attending DCAT Week 2018, taking place March 19-22, in New York City. DCAT Week is the premier business development event for the industry and ensures that DCAT members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities. 

Founded in 1890, DCAT has been providing a life-long collegial community for industry representatives for over 125 years. DCAT’s membership model integrates drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

The analytical service team from WuXi Laboratory Testing Division will be participating in DCAT Week with a meeting suite at the InterContinental New York Barclay. To arrange a meeting, contact: 

Anthony Genovese 
Senior Strategic Account Manager
International Sales & Business Development
Anthony.Genovese@wuxiapptec.com

 

Guy Tiene

Guy supports the success of life science organizations by identifying synergies across research, content, marketing and communications resources to drive value for clients. With over 30 years of education and marketing experience and 18 years in the life sciences alone, Guy leads our editorial standards for client content, Pharma’s Almanac and Nice Insight research-based industry content as well as external communications for clients. Having served as head of global marketing and communications for a CMO, he also brings critical insight and guidance to all communications. Guy holds a Masters degree from Columbia University.

Q: